☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Bintrafusp Alfa
Merck KGaA and GSK Terminate their ~$4.2B Collaboration Due to Clinical Failures
October 4, 2021
Merck KGaA and GSK Discontinue P-II INTR@PID BTC 055 Study of Bintrafusp Alfa as 1L Treatment of Biliary Tract Cancer
August 24, 2021
Load more...
Back to Home
Modal title
×
Modal body text goes here.